title: The "black box" controversy.
authors.affiliation: Office of the Medical Director, Tennessee Department of Mental Health and Developmental Disabilities, Nashville, USA.
authors.forename: Judy
authors.initials: J
authors.lastname: Regan
authors.forename: Mariko
authors.initials: M
authors.lastname: DeWire
authors.forename: Brian
authors.initials: B
authors.lastname: Whitby
authors.forename: Todd
authors.initials: T
authors.lastname: Bess
authors.forename: Arvis
authors.initials: A
authors.lastname: Wright
mesh_terms: D000293:Adolescent; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D003866:Depressive Disorder / Q000188:drug therapy; D004348:Drug Labeling; D006801:Humans; D013714:Tennessee; D014481:United States; D014486:United States Food and Drug Administration; D000092864:Suicide Prevention
chemical_list: D000928:Antidepressive Agents